Stocks and Investing Stocks and Investing
Fri, July 7, 2023
Thu, July 6, 2023
Wed, July 5, 2023
Mon, July 3, 2023

Whitney Ijem Maintained (BMRN) at Hold with Decreased Target to $104 on, Jul 3rd, 2023


Published on 2024-10-28 04:37:35 - WOPRAI, Whitney Ijem
  Print publication without navigation


Whitney Ijem of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Decreased Target from $110 to $104 on, Jul 3rd, 2023.

Whitney has made no other calls on BMRN in the last 4 months.



There are 10 other peers that have a rating on BMRN. Out of the 10 peers that are also analyzing BMRN, 4 agree with Whitney's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andreas Argyrides of "Wedbush" Maintained at Hold with Increased Target to $73 on, Friday, June 30th, 2023
  • David Lebowitz of "Citigroup" Maintained at Hold with Decreased Target to $96 on, Friday, June 30th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $100 on, Thursday, April 27th, 2023
  • Kostas Biliouris of "BMO Capital" Maintained at Hold with Decreased Target to $102 on, Tuesday, March 7th, 2023


These are the ratings of the 6 analyists that currently disagree with Whitney


  • Joel Beatty of "Baird" Reiterated at Buy and Held Target at $127 on, Friday, June 30th, 2023
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $140 on, Friday, June 30th, 2023
  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $120 on, Wednesday, June 14th, 2023
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Decreased Target to $120 on, Thursday, April 27th, 2023
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $125 on, Thursday, April 27th, 2023
  • William Pickering of "Bernstein" Initiated at Sell and Held Target at $81 on, Tuesday, March 21st, 2023